Guilin Sanjin Pharmaceutical Co., a maker of traditional Chinese medicines, will be the first China IPO of any sector in 2009. The company is planning to make its debut on June 29 on the Shenzhen exchange. China regulators banned IPOs nine months ago, after the Shanghai Composite Index fell 60% in 2008. Guilin Sanjin will issue up to 46 million new shares to fund 10 projects that will require 634 million RMB ($93 million) of investment. More details...